Gout is associated with worse post-PCI long term outcomes.

Aim: We aimed to assess the long-term outcomes of patients with gout
who underwent percutaneous coronary intervention.
Methods: A Retrospective cohort study of all adult (>18 years) patients who
underwent PCI in a large [1000 bed] tertiary care centerfrom January 2002 to August 2020.
Results: A total of 12,951 patients underwent PCI during the study period and were
included in the cohort, of which 344 (2.7%) had a gout. The composite endpoint of
mortality, ACS or CHF admission was more
frequent in the gout group (73.8% vs 59.5%, p< 0.001). The adjusted cox regression
model found a statistically significant increased risk of the composite primary endpoints of around
20% for patients both with gout, driven mainly by increased risk for ACS and CHF admissions.
Conclusion: Gout is associated with significantly increased post-PCI cardiovascular
risk. Therefore, patients with gout should be considered as a higher risk cohort and be
treated accordingly